Insider Transactions in Q3 2020 at Arcutis Biotherapeutics, Inc. (ARQT)
Insider Transaction List (Q3 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2020
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
6,000
-0.53%
|
$180,000
$30.0 P/Share
|
|
Sep 29
2020
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+0.52%
|
$6,000
$1.68 P/Share
|
|
Sep 29
2020
|
John W Smither Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
1,250
-1.25%
|
$37,500
$30.0 P/Share
|
|
Sep 29
2020
|
John W Smither Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
500
-2.05%
|
$15,000
$30.0 P/Share
|
|
Sep 29
2020
|
John W Smither Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+2.01%
|
$500
$1.68 P/Share
|
|
Sep 29
2020
|
David W Osborne Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-5.37%
|
$450,000
$30.0 P/Share
|